|
ZNF614 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.955890E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66470000000563E-05 |
| Normal-vs-Stage2 |
7.276000E-01 |
| Normal-vs-Stage3 |
9.059600E-01 |
| Normal-vs-Stage4 |
1.286040E-01 |
| Stage1-vs-Stage2 |
3.195900E-02 |
| Stage1-vs-Stage3 |
8.005700E-04 |
| Stage1-vs-Stage4 |
4.02339999999723E-05 |
| Stage2-vs-Stage3 |
6.973000E-01 |
| Stage2-vs-Stage4 |
1.794850E-01 |
| Stage3-vs-Stage4 |
2.190200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.309600E-02 |
| Normal-vs-AfricanAmerican |
4.514000E-01 |
| Normal-vs-Asian |
8.612600E-01 |
| Caucasian-vs-AfricanAmerican |
9.676000E-01 |
| Caucasian-vs-Asian |
7.674600E-01 |
| AfricanAmerican-vs-Asian |
7.226200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.292200E-01 |
| Normal-vs-Female |
7.356600E-04 |
| Male-vs-Female |
2.204300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.361200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.517680E-02 |
| Normal-vs-Age(61-80Yrs) |
1.238610E-01 |
| Normal-vs-Age(81-100Yrs) |
7.111600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.986600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.736200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.713000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.304800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.268400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.070800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.844100E-02 |
| Normal-vs-Grade 2 |
1.33330000040566E-07 |
| Normal-vs-Grade 3 |
1.294420E-01 |
| Normal-vs-Grade 4 |
3.655700E-02 |
| Grade 1-vs-Grade 2 |
3.752800E-01 |
| Grade 1-vs-Grade 3 |
6.603700E-02 |
| Grade 1-vs-Grade 4 |
3.830200E-02 |
| Grade 2-vs-Grade 3 |
9.17030007485664E-10 |
| Grade 2-vs-Grade 4 |
1.16659999993551E-07 |
| Grade 3-vs-Grade 4 |
2.210200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.84690000146904E-08 |
| Normal-vs-ccB subtype |
5.262200E-01 |
| ccA subtype-vs-ccB subtype |
2.943800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.295830E-01 |
| Normal-vs-N1 |
4.048200E-01 |
| N0-vs-N1 |
1.654760E-01 |
|
|
